Effects of lung recruitment maneuver and positiveend-expiratory pressure on lung volume, respiratory mechanics and alveolar gas mixing in patients ventilated after cardiac surgery

2002 ◽  
Vol 46 (6) ◽  
pp. 717-725 ◽  
Author(s):  
T. Dyhr ◽  
N. Laursen ◽  
A. Larsson
2010 ◽  
Vol 58 (S 01) ◽  
Author(s):  
AH Kiessling ◽  
F Isgro ◽  
M Neher ◽  
A Lehmann ◽  
A Kornberger ◽  
...  

2013 ◽  
Vol 28 (4) ◽  
pp. 534.e1-534.e5 ◽  
Author(s):  
Susumu Nakahashi ◽  
Satoshi Gando ◽  
Takehiko Ishikawa ◽  
Takeshi Wada ◽  
Yuichiro Yanagida ◽  
...  

2005 ◽  
Vol 31 (9) ◽  
pp. 1189-1194 ◽  
Author(s):  
Jonas Nielsen ◽  
Morten Østergaard ◽  
Jesper Kjaergaard ◽  
Jens Tingleff ◽  
Preben G. Berthelsen ◽  
...  

Author(s):  
A E Bautin

The aim. To estimate efficacious of combined application of lung recruitment maneuver (LR) and surfactant administration for the treatment of ARDS after cardiac surgery. Materials and methods. 33 cardiac surgery patients with ARDS were included in to prospective, controlled non-randomized study. LR technique was used in 14 patients, who were included into the "LR" group. In 19 cases LR were combined with endobronchial administration of surfactant (Surfactant-BL, ”Biosurf” Russia), these patients were included into the "LR and surfactant" group. Results. Significant difference from baseline FiO 2 observed after 12 h in "LR and surfactant" group and after 24 h in "LR" group. Significant decrease from the baseline PEEP was observed after 48 h in "LR and surfactant" group and after 72 h in "LR" group. The duration of respiratory support was shorter in the "LR and surfactant" group: 87,5 ± 35,3 h vs 175,3 ± 52,5, p <0,001. There was significant difference in the incidences of ventilator-associated pneumonia (VAP): 10.5% in the "LR and surfactant" group and 42.9% in the "LR" group, p <0,05. Furthermore, we found significant difference in the ICU stay period between groups: 132,5 ± 42,2 h in the "LR and surfactant" group vs 282,5 ± 110,2 h in the "LR" group, p <0,01. There was no significant difference between two groups In mortality rate: 3 (15.8%) in the "LR and surfactant" group and 3 (21.4%) in the "LR" group. Conclusions. The combination of LR and surfactant administration decrease the time of respiratory support and ICU stay, reduce the risk of VAP.


Sign in / Sign up

Export Citation Format

Share Document